Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

February 21, 2012

Primary Completion Date

October 21, 2015

Study Completion Date

October 21, 2015

Conditions
Prostate Cancer
Interventions
DRUG

NX-1207 2.5 mg

A single intraprostatic injection of NX-1207 2.5 mg followed by active surveillance.

DRUG

NX-1207 15 mg

A single intraprostatic injection of NX-1207 15 mg followed by active surveillance.

Trial Locations (23)

10016

For information concerning this clinical site, please contact Nymox at 800-936-9669., New York

11530

For information concerning this clinical site, please contact Nymox at 800-936-9669., Garden City

21204

For information concerning this clinical site, please contact Nymox at 800-936-9669., Baltimore

21401

For information concerning this clinical site, please contact Nymox at 800-936-9669., Annapolis

29572

For information concerning this clinical site, please contact Nymox at 800-936-9669., Myrtle Beach

33180

For information concerning this clinical site, please contact Nymox at 800-936-9669., Aventura

34102

For information concerning this clinical site, please contact Nymox at 800-936-9669., Naples

38138

For information concerning this clinical site, please contact Nymox at 800-936-9669., Germantown

47130

For information concerning this clinical site, please contact Nymox at 800-936-9669., Jeffersonville

71106

For information concerning this clinical site, please contact Nymox at 800-936-9669., Shreveport

75010

For information concerning this clinical site, please contact Nymox at 800-936-9669., Carrollton

80113

For information concerning this clinical site, please contact Nymox at 800-936-9669., Englewood

80220

For information concerning this clinical site, please contact Nymox at 800-936-9669., Denver

84124

For information concerning this clinical site, please contact Nymox at 800-936-9669., Salt Lake City

85715

For information concerning this clinical site, please contact Nymox at 800-936-9669., Tucson

87109

For information concerning this clinical site, please contact Nymox at 800-936-9669., Albuquerque

89148

For information concerning this clinical site, please contact Nymox at 800-936-9669., Las Vegas

90806

For information concerning this clinical site, please contact Nymox at 800-936-9669., Long Beach

91942

For information concerning this clinical site, please contact Nymox at 800-936-9669., La Mesa

92120

For information concerning this clinical site, please contact Nymox at 800-936-9669., San Diego

94027

For information concerning this clinical site, please contact Nymox at 800-936-9669., Atherton

06052

For information concerning this clinical site, please contact Nymox at 800-936-9669., New Britain

08724

For information concerning this clinical site, please contact Nymox at 800-936-9669., Brick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nymox Corporation

INDUSTRY